134 results
8-K
EX-99.1
KALA
Kala Bio Inc.
14 May 24
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:06pm
-based compensation costs and employee related costs.
R&D Expenses: For the quarter ended March 31, 2024, research and development (R&D) expenses were … and employee-related costs, as we advance the clinical development of KPI-012, and an increase in other research and development costs.
Gain on Fair Value
S-8
KALA
Kala Bio Inc.
29 Mar 24
Registration of securities for employees
8:21am
2017 Employee Stock Purchase Plan
Inducement Stock Option Awards (June 23, 2023 – January 16, 2024))
(Full Title of the Plan)
Mark Iwicki
Chief … . Registrant Information and Employee Plan Annual Information.
The written statement required by Item 2 is omitted from this registration statement
S-8
EX-5.1
toimjomeir
29 Mar 24
Registration of securities for employees
8:21am
S-8
02lbfp 9dbgcyibrrr8
29 Mar 24
Registration of securities for employees
8:21am
8-K
EX-99.1
niv5l
29 Mar 24
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
8:01am
8-K
EX-10.1
xode r5rfj6
26 Mar 24
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
00ax8 618tieyl5
22 Dec 23
Entry into a Material Definitive Agreement
8:22am
8-K
EX-99.1
rm6f8rcpf
13 Nov 23
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:05am